Mohamed Labib Salem1,2, Mohamed R El-Shanshory1,3, Said H Abdou1,4, Mohamed S Attia1,4, Shymaa M Sobhy1,2, Mona F Zidan1,2, Abdel-Aziz A Zidan1,5. 1. a Center of Excellence in Cancer Research (CECR), Tanta University , Tanta , Egypt. 2. b Department of Zoology, Faculty of Science , Tanta University , Tanta , Egypt. 3. c Pediatric Oncology, Faculty of Medicine , Tanta University , Tanta , Egypt. 4. d Clinical Pathology, Faculty of Medicine , Tanta University , Tanta , Egypt. 5. e Department of Zoology , Damanhour University , Damanhour , Egypt.
Abstract
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The precise mechanism behind the relapse in this disease is not clearly known. One possible mechanism could be the accumulation of immunosuppressive cells, including myeloid-derived suppressor cells (MDSCs) and T regulatory cells (Tregs) which we and others have reported to mediate suppression of anti-tumor immune responses. AIM: In this study, we aimed to analyze the numbers of these cells in a population of B-ALL pediatric patients. METHODS: Peripheral blood samples withdrawn from B-ALL pediatric patients (n = 45 before, during and after the induction phase of chemotherapy. Using multi parametric flow cytometric analysis. MDSCs were identified as Lin-HLA-DR-CD33+CD11b+; and Treg cells were defined as CD4+CD25+CD127-/low. RESULTS: Early diagnosed B-ALL patients showed significant increases in the numbers of MDSCs and Tregs as compared to healthy volunteers. During induction of chemotherapy, however, the patients showed higher and lower numbers of MDSCs and Treg cells, respectively as compared to early diagnosed patients (i.e., before chemotherapy). After induction of chemotherapy, the numbers of MDSCs and Treg cells showed higher increases and decreases, respectively as compared to the numbers in patients during chemotherapy. CONCLUSION: Our results indicate that B-ALL patients harbor high numbers of both MDSCs and Tregs cells. This pilot study opens a new avenue to investigate the mechanism mediating the emergence of these cells on larger number of B-ALL patients at different treatment stages.
INTRODUCTION:Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children. The precise mechanism behind the relapse in this disease is not clearly known. One possible mechanism could be the accumulation of immunosuppressive cells, including myeloid-derived suppressor cells (MDSCs) and T regulatory cells (Tregs) which we and others have reported to mediate suppression of anti-tumor immune responses. AIM: In this study, we aimed to analyze the numbers of these cells in a population of B-ALL pediatric patients. METHODS: Peripheral blood samples withdrawn from B-ALL pediatric patients (n = 45 before, during and after the induction phase of chemotherapy. Using multi parametric flow cytometric analysis. MDSCs were identified as Lin-HLA-DR-CD33+CD11b+; and Treg cells were defined as CD4+CD25+CD127-/low. RESULTS: Early diagnosed B-ALL patients showed significant increases in the numbers of MDSCs and Tregs as compared to healthy volunteers. During induction of chemotherapy, however, the patients showed higher and lower numbers of MDSCs and Treg cells, respectively as compared to early diagnosed patients (i.e., before chemotherapy). After induction of chemotherapy, the numbers of MDSCs and Treg cells showed higher increases and decreases, respectively as compared to the numbers in patients during chemotherapy. CONCLUSION: Our results indicate that B-ALL patients harbor high numbers of both MDSCs and Tregs cells. This pilot study opens a new avenue to investigate the mechanism mediating the emergence of these cells on larger number of B-ALL patients at different treatment stages.
Authors: Dalia Mahmoud Eldewi; Hanan A El-Hagrasy; Rasha Mahmoud Gouda; Mohammed Abd El Malik Hassan; Shimaa Moustafa Kamel; Naglaa F Abd El Haliem; Haneya A A Anani Journal: Int J Gen Med Date: 2022-08-07
Authors: Rodolfo Daniel Cervantes-Villagrana; Damaris Albores-García; Alberto Rafael Cervantes-Villagrana; Sara Judit García-Acevez Journal: Signal Transduct Target Ther Date: 2020-06-18
Authors: Jaris Valencia; Lidia M Fernández-Sevilla; Alberto Fraile-Ramos; Rosa Sacedón; Eva Jiménez; Angeles Vicente; Alberto Varas Journal: Cells Date: 2019-07-14 Impact factor: 6.600
Authors: Asmaa M Zahran; Azza Shibl; Amal Rayan; Mohamed Alaa Eldeen Hassan Mohamed; Amira M M Osman; Khaled Saad; Khaled Hashim Mahmoud; Aliaa M A Ghandour; Khalid I Elsayh; Omnia El-Badawy Journal: Sci Rep Date: 2021-07-22 Impact factor: 4.379